Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
Here are some of the Duke Cancer Institute faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
Here are some of the Duke Cancer Institute faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
In observance of Blood Cancer Awareness Month, Denise Spector, PhD, shares her husband's final months spent fighting cancer and thanks his heroes on 9100.
For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.
DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.
Wrestling with “next generation sequencing," a new molecular registry of tumors is helping Duke oncologists deliver patient- centered precision cancer medicine.
What does it take to be a great oncology nurse? Joey Misuraca, RN, the nurse manager on the 9100 unit of Duke University Hospital, where seriously ill...
Led by a team from Duke, an international group of 56 researchers has found new mutations identifying potential treatments and new hope for patients w...
Duke Cancer Institute researchers are attending the American Society of Hematology’s (ASH) 59th Annual Meeting & Exposition in Atlanta this week.Here ...